AVMA revises biotechnology policy
Schaumburg, Ill. -- The American Veterinary Medical Association?s (AVMA) Executive Board revised its policy on ?Use of Biotechnology in Development of Drugs and Vaccines? in April.
Schaumburg, Ill.
-- The American Veterinary Medical Association’s (AVMA) Executive Board revised its policy on “Use of Biotechnology in Development of Drugs and Vaccines” in April.
The revisions officially recognize the importance of biotechnology in drug and vaccine development, revealing how biotechnology use can help enhance surveillance and evaluate new developments with a science-based approach.
The amended policy can be found here.
dvm360 announces winners of the Veterinary Heroes program
Published: September 6th 2024 | Updated: November 5th 2024This year’s event is supported by corporate sponsor Schwarzman Animal Medical Center and category sponsors Blue Buffalo Natural, MedVet, Banfield Pet Hospital, Thrive Pet Healthcare and PRN Pharmacal.
Read More
